News Room
George Galloway wins divisive Rochdale by-election
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.George Galloway…
Bud Stock Falls After Earnings. It’s Not All Bad News for Anheuser-Busch.
Almost a year after Bud Light’s involvement with transgender influencer Dylan Mulvaney triggered a broad consumer boycott of the brand,…
Australia threatens action against Meta after Facebook news payments axed
Stay informed with free updatesSimply sign up to the Technology sector myFT Digest -- delivered directly to your inbox.The Australian…
Snowflake, Okta, C3.ai, Duolingo, Chemours, Hormel, AMC, Pure Storage, and More Movers
The Nasdaq Composite locked in its first record close since 2021 after the Federal Reserve’s preferred inflation gauge, the core…
The alternate universe in which Tottenham are top
Back in October, the headteacher at my son’s school began each assembly by displaying the Premier League table, with Tottenham…
PC Sales Are Sputtering Again. The AI Boost Isn’t Here Yet.
A broad-based recovery in PC demand isn’t happening—yet. For months, Wall Street analysts and industry executives have been hoping that…
Cobalt market stung by record oversupply
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.The cobalt…
Viking Therapeutics’ promising weight-loss drug data makes the company a takeover target
Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to 145%, as analysts weighed in on…